YKL-40 release is inhibited by dexamethasone in MΦ1 in vitro, whereas long-term treatment of COPD patients with inhaled corticosteroids did not significantly change YKL-40 levels in serum and sputum. This evidence concerns the gene CHI3L1 and chronic obstructive pulmonary disease.